Following the FOMC meeting, the DXY Index retreated from its intra-day high of 103.9 to 103.5, ending the session higher by 0.2% for the first time in four days. Despite the Fed revising its 2025 core PCE inflation forecast upward to 2.8% from 2.5% (previously projected in December), the US Treasury 10Y yield declined by 4 bps to 4.24% for the third session. The Fed made no changes to the direction and magnitude of its December rate-cut projections, maintaining expectations for two cuts in 2025, two in 2026, and 1-2 in 2027.
While the Fed attributed this year’s higher inflation to tariffs, it maintained its forecast for inflation to resume its decline over 2026-2027 to the 2% target on modestly slower GDP growth slightly below 2% over its forecast horizon. The updated outlook reflected higher short-term inflation expectations over the next 12 months, while longer-term expectations remained steady. The S&P 500 Index rose 1.1% to 5675, with investors encouraged by the Fed playing down “Trumpcession” fears and hopes of more Fed cuts to support growth.
Although the Fed’s inflation forecasts appeared to align with US Treasury Scott Bessant’s assessment that the impact of inflation from Trump’s tariffs would be transitory, Fed Chair Jerome Powell stressed that the forecasts could change because of the unusually elevated level of uncertainty. Before the FOMC, many Fed officials reckoned tariffs would be inflationary if the US and other countries engaged in a lasting tit-for-tat tariff war, a prospect which markets cannot rule out because of Trump’s upcoming reciprocal tariffs in April. All said, the DXY is still inside the 103-104 range set on March 10th.
BANK OF ENGLAND MEETING
Per our BOE Meeting preview note on Monday, we expect the Bank of England is expected to keep its bank rate unchanged at 4.50% today. Following its 25 bps cut on February 6th, the BOE expected higher global energy costs and regulated price changes to lift CPI inflation to 3.7% YoY in 3Q25 before resuming its decline to the 2% target. Indeed, CPI inflation rose to 3% YoY in January from 2.5% in December, while core inflation increased to 3.7% from 3.2%. However, this did not deter the OIS market from pricing two more BOE cuts in May and September this year. BOE Governor Andrew Bailey told the House of Commons Treasury Committee on March 5th that the US-led trade war was the wrong way to fix imbalances by exposing the UK and world economies to substantial risks. While GBP/USD kept near its pivotal 1.30 level, GBP bulls should be mindful of the retreat in the 10Y Gilt yield from its 2.94% high to 2.80% over the past week.
Apart from growth risks from tariffs, GBP bulls should be mindful of Chancellor of the Exchequer Rachel Reeves’ Spring Budget on March 26th. The Chancellor will struggle to meet its self-imposed fiscal rules because of disappointing growth, higher borrowing costs, and Prime Minister Keir Starmer’s commitment to bolster defence spending. Following the 0.1% contraction in January’s GDP, the Office of Budget Responsibility (OBR) will likely lower 2025’s growth forecast from 2%. Reeves faces difficult choices to meet the fiscal rules, with each option (e.g. higher taxes and welfare spending cuts) carrying significant political and economic consequences with potential backlash from MPs and voters.
SWISS NATIONAL BANK MEETING
USD/CHF is at the floor of a two-week range between 0.8760 and 0.8865. The Swiss National Bank is widely expected to lower rates for the fifth time by 25 bps to 0.25%, which the OIS market reckoned could be the final cut for 2025. Due to a strong CHF and a sluggish economy, February CPI and core inflation were subdued at 0.3% YoY and 0.9%, respectively. On March 1st, the SNB indicated readiness to reintroduce negative interest rates (if necessary) to keep inflation within the official 0-2% target and expressed openness to forex interventions to counter the CHF’s haven status.
However, a lot has changed since March 1st. Although the SNB forecasted the Swiss economy to expand by 1-1.5% in 2025 vs. 1.3% in 2024, the outlook faces downside risks. The EU economy is pulled in both directions from the US-EU tariff spat against heightening global trade tensions and the European Commission’s proposal for a “ReArm Europe” Plan. The Swiss economy is not immune to Trump’s threat to impose a 25% tariff on pharmaceutical products in April. America has been Switzerland’s most important goods market after the Covid-19 pandemic, with pharmaceutical products representing about half of its exports to the US.
Quote of the Day
“Strive not to be a success, but rather to be of value.”
Albert Einstein
March 20 in history
Albert Einstein submitted his paper, "The Foundation of the General Theory of Relativity", in 1916.
GENERAL DISCLOSURE/ DISCLAIMER (For Macroeconomics, Currencies, Interest Rates)
The information herein is published by DBS Bank Ltd and/or DBS Bank (Hong Kong) Limited (each and/or collectively, the “Company”). It is based on information obtained from sources believed to be reliable, but the Company does not make any representation or warranty, express or implied, as to its accuracy, completeness, timeliness or correctness for any particular purpose. Opinions expressed are subject to change without notice. This research is prepared for general circulation. Any recommendation contained herein does not have regard to the specific investment objectives, financial situation and the particular needs of any specific addressee. The information herein is published for the information of addressees only and is not to be taken in substitution for the exercise of judgement by addressees, who should obtain separate legal or financial advice. The Company, or any of its related companies or any individuals connected with the group accepts no liability for any direct, special, indirect, consequential, incidental damages or any other loss or damages of any kind arising from any use of the information herein (including any error, omission or misstatement herein, negligent or otherwise) or further communication thereof, even if the Company or any other person has been advised of the possibility thereof. The information herein is not to be construed as an offer or a solicitation of an offer to buy or sell any securities, futures, options or other financial instruments or to provide any investment advice or services. The Company and its associates, their directors, officers and/or employees may have positions or other interests in, and may effect transactions in securities mentioned herein and may also perform or seek to perform broking, investment banking and other banking or financial services for these companies. The information herein is not directed to, or intended for distribution to or use by, any person or entity that is a citizen or resident of or located in any locality, state, country, or other jurisdiction (including but not limited to citizens or residents of the United States of America) where such distribution, publication, availability or use would be contrary to law or regulation. The information is not an offer to sell or the solicitation of an offer to buy any security in any jurisdiction (including but not limited to the United States of America) where such an offer or solicitation would be contrary to law or regulation.
[#for Distribution in Singapore] This report is distributed in Singapore by DBS Bank Ltd (Company Regn. No. 196800306E) which is Exempt Financial Advisers as defined in the Financial Advisers Act and regulated by the Monetary Authority of Singapore. DBS Bank Ltd may distribute reports produced by its respective foreign entities, affiliates or other foreign research houses pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the report is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, DBS Bank Ltd accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact DBS Bank Ltd at 65-6878-8888 for matters arising from, or in connection with the report.
DBS Bank Ltd., 12 Marina Boulevard, Marina Bay Financial Centre Tower 3, Singapore 018982. Tel: 65-6878-8888. Company Registration No. 196800306E.
DBS Bank Ltd., Hong Kong Branch, a company incorporated in Singapore with limited liability. 18th Floor, The Center, 99 Queen’s Road Central, Central, Hong Kong SAR.
DBS Bank (Hong Kong) Limited, a company incorporated in Hong Kong with limited liability. 11th Floor, The Center, 99 Queen’s Road Central, Central, Hong Kong SAR.
Virtual currencies are highly speculative digital "virtual commodities", and are not currencies. It is not a financial product approved by the Taiwan Financial Supervisory Commission, and the safeguards of the existing investor protection regime does not apply. The prices of virtual currencies may fluctuate greatly, and the investment risk is high. Before engaging in such transactions, the investor should carefully assess the risks, and seek its own independent advice.